Le Lézard
Classified in: Health, Business
Subjects: FNC, VEN

Two Chairs Secures $72M in Equity and Debt to Expand Its Unique Matching, Measurement-Based Care


With 74% of patients showing meaningful improvement, Two Chairs is raising the bar on mental health outcomes

SAN FRANCISCO, April 16, 2024 /PRNewswire-PRWeb/ -- Two Chairs, a modern behavioral health company, today announced the closing of a $72 million Series C equity and debt financing round led by Amplo with Fifth Down Capital, and other investors also participating. Bridge Bank provided the debt financing. This latest round brings the total capital raised to $103M. Two Chairs has grown 8x over the last 36 months and now has more than 500 clinicians on staff. This new infusion of capital will further expand Two Chairs' reach, making mental health care more accessible and effective.

At our core, we are committed to ensuring everyone has access to exceptional mental healthcare. This additional funding will enable us to deepen our investments in technology, and accelerate our growth, all in the service of extending our lead in care quality...

"Two Chairs epitomizes quality in behavioral health, taking an extraordinarily thoughtful approach, and you can see it in their outcomes data," said Sheel Tyle, Founder & CEO of Amplo. "Industry-wide, only about a third of patients progress to their fourth therapy session, whereas for Two Chairs, 90% of their patients do. We proudly invest in thriving companies where quality is a core advantage. Two Chairs has been growing quickly?in all the right ways and for all the right reasons."

Two Chairs focuses on great alliances between therapists and their clients, which, studies have shown, is the single most important determiner of good mental health outcomes. The unique "matching consult," aided by a proprietary 300-variable algorithm, helps create the right therapist match for the client, setting them up for success: 97% of Two Chairs clients agree that the alliance with their therapist is strong.

In addition, Two Chairs' leading approach to measurement-based care tracks therapeutic progress, providing real-time insight into a client's well-being, allowing therapists to personalize treatment plans, empower clients, and strengthen the therapeutic connection. Two Chairs has invested deeply in a differentiated full-time clinician experience with the belief that quality care is delivered by clinicians who feel supported and satisfied with their work.

"At our core, we are committed to ensuring everyone has access to exceptional mental healthcare. This additional funding will enable us to deepen our investments in technology, and accelerate our growth, all in the service of extending our lead in care quality," said Two Chairs CEO and Founder, Alex Katz. "By matching patients with the right therapists, we are creating better outcomes for both sides."

Two Chairs offers a hybrid care approach with in-person and virtual therapy with offices in multiple cities in California, Washington state, and Florida. Two Chairs has plans to grow into additional states in the next 12 months. With an in-network model, Two Chairs works with Aetna nationally and Kaiser Permanente in Washington and Northern California, allowing their members to get top quality care for the price of a copay or coinsurance. Additional healthcare partnerships will be finalized in 2024.

About Two Chairs

Two Chairs delivers the nation's best therapy at scale. Founded in 2017, the company's mission is to build a world where we all have access to exceptional mental health care. Their unique approach begins with an in-depth, research-backed process where a licensed Two Chairs clinician matches patients with their ideal therapist. Two Chairs then uses their industry-leading system for measurement-based care to help patients get better, faster. Two Chairs is the employer of choice for over 500 licensed therapists across 90 areas of expertise and has more than 20 million covered lives. The company has earned a number of awards, including 2024 Great Place To Work and San Francisco Business Times Best Places To Work.

Media Contact

Ann Noder, Pitch Public Relations, 1 480-263-1557, [email protected], www.pitchpublicrelations.com

SOURCE Two Chairs


These press releases may also interest you

at 06:05
Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer's disease (AD) and other neurodegenerative disorders, today announced the dosing...

at 06:05
Aurinia Pharmaceuticals Inc. (Aurinia or the Company) today announced that the FDA has approved a label update for LUPKYNIS. The updated label no longer includes language indicating that the safety and efficacy of LUPKYNIS has not been established...

at 06:05
Generate:Biomedicines today announces two key appointments, welcoming Kimberly (Kym) White as the new Chief Corporate Affairs Officer and announcing the promotion of Lisa Wyman to Chief Technical Operations Officer. These appointments not only...

at 06:04
Photocure ASA today announces the publication of the Annual Report and integrated ESG report for 2023. The Board of Directors of Photocure ASA has approved the annual accounts for 2023. The financial statements and annual report for the financial...

at 06:00
AVRICORE HEALTH INC. (the "Company" or "AVCR") is pleased to announce its audited results for 2023. The Company nearly doubled its previous record revenues to $3,485,147 while gross profit increased by 163% to...

at 06:00
Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the...



News published on and distributed by: